|
Weekly Update | June 1, 2010 |
|
|
The
Partnership for Safe Medicines (PSM) Counterfeits Dialogue Breakfast
This Friday, June 4, the PSM will
work in concert with the Irish Patients' Association to present a counterfeits dialogue breakfast at the Shelbourne Hotel in Dublin, Ireland.
We are honored to be joined by Mary Haney,
Ireland's Minister of Health and Children, to discuss threats to patient safety
caused by unsafe medicines, and how to work collaboratively
with healthcare practitioners and distributors of medicines to raise awareness
of counterfeit and unsafe medicines around the globe. PSM Executive
Director Scott LaGanga will also be on hand to present at the event.
More soon from Dublin. |
|
Top News
Herbal Supplements
Often Contaminated, Study Says
The New
York Times reports that of all of the herbal dietary supplements recently
tested as part of a Congressional investigation, most contained some amounts of
contaminants, including the dangerous toxic metal, lead. Dr. Joshua M.
Sharfstein, the principal deputy commissioner of the U.S. Food and Drug
Administration (FDA), said in an interview that he was not concerned about the
supplements the GAO tested, but did discuss how the FDA just announced a recall
of Vita Breath, a dietary supplement that may contain hazardous levels of lead.
The New York City Department of Health and Mental Hygiene notified the FDA
about a patient with lead poisoning who reported taking Vita Breath and two
other herbal products. The department analyzed a sample of Vita Breath and
reported that it contained 1,100 parts per million of lead, which is more than
10,000 times higher than FDA's maximum recommended level for lead in candy. ("Study
Finds Herbal Supplements Often Tainted," News Inferno, May 26, 2010; Story here)
|
World News
United States: Generics Manufacturer Faces Scrutiny
for Contaminated Pills Perrigo Co.,
the world's largest maker of non-prescription, store-branded drugs, was forced
to pull contaminated ibuprofen tablets released by its Allegan, Michigan,
plant. Perrigo failed to protect consumers from ibuprofen tablets contaminated
with metal shavings, U.S.
regulators said. The company had not thoroughly investigated why some tablets
were the wrong size and did not inspect packaging equipment between batches,
the agency said. The warning follows Perrigo's 2006 recall of 11 million
bottles of acetaminophen pills containing pieces of wire as long as 8
millimeters (0.32 inches). The FDA ordered the company to fix its quality-control
issues or face product seizure, injunction or a ban on exports or new product
approvals. ("Perrigo Plant Released Drugs Contaminated With Metal," Business
Week, May 25, 2010; Story
here) India: Counterfeit Drugs Common in
Chennai and other Cities At least
five percent of drugs sold by Chennai pharmacies are substandard, a new study
released by the International Policy Network (IPN) has claimed. London-based
scientists from the IPN and researchers from Delhi's
Liberty Institute conducted tests on five groups of commonly prescribed 'essential'
drugs collected from pharmacies in Chennai and Delhi. The study found that around 38 percent
of chemists in Chennai and 80 percent of Delhi's
medical shops stock or sell substandard or counterfeit drugs. ("City Sold on
Fake Drugs: Study," Deccan Chronicle, May 21, 2010; Story
here) Counterfeit
Drugs Continue to Cause Problems Around the World The World
Health Organization (WHO) estimates that up to ten percent of globally traded
drugs are counterfeit. In September 2009, a 29-year old University
of Maryland pharmacologist died
following an allergic reaction to a counterfeit version of a drug that was
legal in the United States
but had been purchased online from the Philippines. In 2007, the FDA
examined nearly 4,000 packages at airports in New York, Miami and Los Angeles
and found 85 percent of drugs ordered from what customers initially believed
were Canadian pharmacies actually came from 27 other countries. A number of
products were also counterfeit. In response, the Food and Drug Administration
has opened offices in India
and China
in an attempt to monitor more closely the increasing numbers of pharmaceutical
manufacturers in those countries. ("Counterfeit drugs are a global problem," Delmarva
Health Source, May 25, 2010; Story
here)
|
Events
The Partnership for Safe Medicines (PSM) Counterfeits
Dialogue Breakfast When: Friday, Jun 4, 2010 Where: Shelbourne Hotel Dublin Ireland The PSM proudly presents this informative and educational breakfast with the Irish
Patients' Association.
The Drug Information Association 46th Annual Meeting When: Sunday, Jun 13, 2010 Where: Washington D.C. Description: Link
here 5th Global Pharma Manufacturing Summit When: Monday, Jun 14, 2010 Where: Boston, MA Description: Link
here Global Pharma Authentication When: Monday, Jun 14, 2010 Where: Munich, Germany Description: Link here 4th Annual Pharmaceutical Anti-Counterfeiting Strategies
Conference When: Tuesday, Sep 7, 2010 Where: London, UK Description: Link here
PSM's Inaugural 2010
Interchange When: Friday, Oct 8, 2010 Where: Washington, D.C. Description: The Partnership for Safe
Medicines invites you to save the date for an intimate conference
bringing together patient groups, providers, pharmaceutical company quality
experts, enforcement personnel, policymakers, regulatory agency experts and
other interested parties to discuss key issues around counterfeit drugs and
other unsafe medicines. Link
here. |
|
About the Partnership for Safe Medicines
The Partnership for Safe Medicines is a group of organizations and individuals that have policies, procedures, or programs to protect consumers from counterfeit or contraband medicines. For more information, please visit SafeMedicines.org.
| |
|